Clinical trials
General Population (no Specific Condition or Disease) clinical trials
Below are recruiting general population (no specific condition or disease) clinical trials, each written for real people, not researchers. We’re tracking 10,813 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07280390Recruiting
Microplastics in people with cirrhosis
This trial checks whether tiny plastic particles (microplastics) are present in the liver and body of people with cirrhosis who are having planned surgery or a liver transplant. It aims to understand if microplastics might make liver disease worse.
Chandigarh, ChandigarhAges 18–70 - NCT07280585RecruitingPhase 3
Testing a diabetes drug to slow kidney disease progression
This study tests whether a common diabetes medication (SGLT2 inhibitor) can help people with autosomal dominant polycystic kidney disease (ADPKD) maintain kidney function longer. If you have fast-growing kidney cysts and are between 18 and 60 years old, this trial may be an option.
FeldkirchAges 18–60 - NCT07281456RecruitingPhase 2
Testing a new oral drug for Sjögren's disease safety
This study tests the safety of a daily pill called Tofacitinib for adults with mild-to-moderate Sjögren's disease. It aims to see if this drug helps manage symptoms when other treatments haven't worked well.
Bethesda, MarylandAges 18–75 - NCT07282691Recruiting
Validating eye tests for mild brain injury
This study looks at eye tests for people who had a mild brain injury (mTBI) in the last 1 to 6 months. It aims to better understand and measure eye movement problems that can happen after such an injury.
Philadelphia, PennsylvaniaAges 18–35 - NCT07283159RecruitingPhase 2
Tenecteplase plus a second drug for stroke recovery
This study tests whether giving a second drug (urinary kallidinogenase) after the clot-busting drug tenecteplase can help people with moderate to severe ischemic strokes recover better. It is for patients who started treatment within 4.5 hours of symptoms.
ShenyangAges 18 years+ - NCT07283835RecruitingPhase 2
Study of Cretostimogene for non-muscle invasive bladder cancer
This trial tests a new drug, Cretostimogene, for people with a type of bladder cancer that hasn't spread into the muscle layer (non-muscle invasive) and has not responded to standard BCG treatment. The goal is to see if this drug can help control the cancer and avoid the need for bladder removal surgery.
Beijing, Beijing MunicipalityAges 18 years+ - NCT07284082Recruiting
How Does Menopause and HIV Affect Heart Health in Women?
This study looks at how menopause and HIV together might affect a woman's risk for heart disease. If you are a woman with HIV and are either premenopausal, perimenopausal, or postmenopausal, the researchers want to see if the combination of HIV and menopause creates a higher risk.
San Francisco, CaliforniaAges 18 years+ - NCT07284290RecruitingPhase 4
Brain imaging, thinking, and medication study for Lewy body dementia
This study looks at how brain changes affect attention and thinking in people with Lewy body dementia. It includes brain scans, an EEG, and a medication option to see if it helps with symptoms.
Richmond, VirginiaAges 50–89 - NCT07284719Recruiting
Focused Ultrasound for Parkinson's Tremor
This trial tests a non-invasive treatment called MR-guided focused ultrasound (MRgFUS) to reduce severe tremor in Parkinson's disease. It uses sound waves to target the brain area causing the shaking, without surgery.
AarhusAges 50–80 - NCT07284784RecruitingPhase 2/Phase 3
Buntanetap for Parkinson's disease study
This trial tests an investigational drug called buntanetap in people with Parkinson's disease. It aims to see if the drug can improve symptoms. There are two groups: those who've taken buntanetap before (Cohort 1) and those with a deep brain stimulator (DBS) implant for at least a year (Cohort 2).
Birmingham, AlabamaAges 40–85 - NCT07285642Recruiting
Oxygen levels in muscles and brain in COPD patients
This study measures oxygen levels in your brain and leg muscles during exercise to understand how COPD affects them.
IstanbulAges 40–70 - NCT07285954Recruiting
Mindful walking study for brain health
This study tests whether a mindful walking program (audio-guided walks) can help people with brain conditions like multiple sclerosis, Parkinson's, or Alzheimer's feel more resilient. If you join, you will be randomly assigned to the walking program or a control group, and you'll wear a Fitbit and do some in-person brain tests.
Urbana, IllinoisAges 18–110 - NCT07286370RecruitingPhase 2
Vaccine study for typhoid and salmonella in infants
This study tests a new vaccine that could protect infants against typhoid fever and a serious type of salmonella. If your baby is healthy and within the age range, they may be eligible to participate.
BanjulAges 1 month–6 months - NCT07287189RecruitingPhase 2
SAT-3247 for boys with Duchenne muscular dystrophy
This trial tests a new daily pill called SAT-3247 for boys with Duchenne muscular dystrophy (DMD) who are still able to walk. The goal is to see if it can help slow muscle decline.
Los Angeles, CaliforniaAges 7–9 - NCT07287293Recruiting
Suctioning vs no suctioning when waking from anesthesia
This trial compares two ways of managing your breathing tube when you wake up from general anesthesia: suctioning the tube or not. It aims to see which method is more comfortable and safer for you after surgery.
Samut SakhonAges 18 years+ - NCT07287514Recruiting
Test of two oils on metabolism in adults with insulin resistance
This study compares an oil rich in linoleic acid (a type of omega-6 fat) against a blend oil to see which one better improves metabolism and heart health in people with insulin resistance. It may help if you have insulin resistance and at least one heart risk factor like belly fat, low good cholesterol, or high blood pressure.
Santiago, Santiago MetropolitanAges 20–60 - NCT07290153Recruiting
Psychological health and immunotherapy for TNBC
This study looks at how psychological factors and the immune system affect treatment response in women with triple-negative breast cancer. Researchers will use questionnaires and biological samples to understand these links.
Shanghai, Please SelectAges 18–70 - NCT07290244RecruitingPhase 1
Testing ER-100 safety for glaucoma or NAION patients
This trial tests whether a new drug, ER-100, is safe for people with glaucoma or a sudden optic nerve injury called NAION. It aims to see if the drug can be given without serious side effects.
Glendale, CaliforniaAges 40–85 - NCT07290387Recruiting
Tele-Savvy support program for Latino caregivers
This study offers a program called Tele-Savvy for Latino caregivers to help you care for a loved one with Alzheimer's or a related dementia. You'll learn caregiving tips and get support, all from home using your own device.
Rochester, New YorkAges 18 years+ - NCT07290842Recruiting
Dietary nitrate for high blood pressure kidney injury
This study tests whether a natural substance found in leafy greens (dietary nitrate) can help protect the kidneys of people with high blood pressure and early kidney damage. It may offer a simple dietary way to slow kidney disease.
HerningAges 18–70 - NCT07291154Recruiting
Using an app to improve dialysis quality
This trial tests if a smartphone app (via WeChat) can help people on dialysis better manage their treatment and improve quality of care. It's for adults who have been on regular dialysis for at least 3 months.
Chongqing, Chongqing MunicipalityAges 18–75 - NCT07291245Recruiting
Kawasaki disease match trial: identifying kids who need treatment
This trial is testing a way to match children with Kawasaki disease to the best treatment. It looks at specific symptoms and fever duration to see if a child qualifies for the study, which may help doctors give the right treatment faster.
San Diego, CaliforniaAges 4 weeks–17 years - NCT07291258Recruiting
Long-term health study of children born to transplant mothers
This study follows children born to mothers who had a solid organ transplant (like kidney, liver, or heart) to learn about their long-term health. It may help doctors understand how to better care for these families.
Groningen, Provincie GroningenAges Any age - NCT07292792Recruiting
PrEP support through peer health navigation for people leaving jail
This study tests whether adding a peer health navigator (someone with lived experience who helps with health) to regular re-entry services can help more people learn about and start PrEP, a medicine that prevents HIV.
Dallas, TexasAges 18–99
Hear when a new General Population (no Specific Condition or Disease) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for general population (no specific condition or disease)?
- Yes. Clin2 currently lists 10,813 recruiting general population (no specific condition or disease) studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a general population (no specific condition or disease) trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a general population (no specific condition or disease) trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.